Projects related to 6-2013-2894

Results found (6)
No.CategoryTechnology NameBriefcaseLead Researcher
467
Mechanism-Based Anti-Angiogenic Drug-Combination to Treat Cancer Tiltan Pharma is a start up company that developed a novel treatment for cancer which is now at  a phase-II clinical study in metastatic pancreatic cancer. The company has ...
More
Prof. Ben-Sasson Shmuel
2758
Company Profile: Integra Holdings is a unique venture fund that combines academic excellence, funding and R&D guidance together with a strong and proven business network. Founded by Yissum, Integra focuses on an exclusive selection of ...
More
Patt Liana
3056
Computing Smart Peptides About us: Pepticom Ltd. is an Israeli innovative computational drug discovery company founded on December 2011, privately co-owned by the Hebrew University of Jerusalem, seed investors and the scientific team that ...
More
Prof. Goldblum Amiram
4370
Company Profile Splisense is developing targeted therapies for genetic diseases based on splicing modulation treating the underlying root cause of the disease.   SpliSense’s initial focus is on Cystic Fibrosis. SpliSense is developing a new ...
More
Prof. Kerem Batsheva
4402
Company Profile Tissue Dynamics Ltd. is a groundbreaking biotechnology company advancing smart microphysiological platforms for drug, food, and cosmetic development. The company’s proprietary tissue-embedded micro sensors permit real time ...
More
Nahmias Yaakov
4403
Company Profile OnTimeBio is a cross-indication liquid biopsy (blood test) used to identify disease before symptoms appear. It is valid for cancer, neurological, metabolic, autoimmune, inflammatory and cardiovascular diseases.   A liquid biopsy ...
More
Dor Yuval